Columbia University professors David A. Nadler and Michael L. Tushman developed the congruence model for businesses. This model offers a structured approach to analyzing the key drivers of ...
Congruence Therapeutics a annoncé qu'elle avait conclu un accord de collaboration en matière de recherche avec Ono Pharmaceutical Co. Ltd. (Ono) pour découvrir de nouveaux médicaments candidats en ...
Managers have to understand their businesses to make them more efficient. Theoretical models are critical in this understanding because they provide a conceptual framework for analyzing organizational ...
BDC Capital's Thrive Venture Fund joined to lead the extension. Congruence Therapeutics has secured an additional $20 million CAD ($15 million USD) for its Series A round. The extension saw BDC ...
Congruence pulls in $50M series A to build a team of 'drug hunters' to go after rare disease targets
A new biotech called Congruence Therapeutics snagged $50 million to build a new team of "drug hunters" focused on protein misfolding to go after rare diseases. Congruence Therapeutics just completed a ...
“Too often we idolize a ‘middle’ stance as more rational, more fair, more loving. We wear it as its own kind of moral superiority. But virtue is not synonymous with neutrality. Sometimes integrity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback